S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

Leap Therapeutics (LPTX) News Today

$2.49
+0.03 (+1.22%)
(As of 11/29/2023 ET)
Compare
Today's Range
$2.43
$2.65
50-Day Range
$1.30
$2.86
52-Week Range
$1.24
$10.20
Volume
118,092 shs
Average Volume
186,620 shs
Market Capitalization
$63.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.30
SourceHeadline
finance.yahoo.com logoLeap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference
finance.yahoo.com - November 21 at 7:52 AM
MarketBeat logoLeap Therapeutics (NASDAQ:LPTX) Price Target Cut to $12.00 by Analysts at Mizuho
americanbankingnews.com - November 21 at 3:42 AM
markets.businessinsider.com logoRaymond James Maintains Outperform Rating for Leap Therapeutics: Here's What You Need To Know
markets.businessinsider.com - November 14 at 2:08 PM
finanznachrichten.de logoLeap Therapeutics, Inc.: Leap Therapeutics Reports Third Quarter 2023 Financial Results
finanznachrichten.de - November 13 at 9:31 AM
benzinga.com logoRecap: Leap Therapeutics Q3 Earnings
benzinga.com - November 13 at 9:31 AM
finance.yahoo.com logoLeap Therapeutics Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 13 at 9:31 AM
finance.yahoo.com logoLeap Therapeutics to Participate at Upcoming Investor Conferences
finance.yahoo.com - September 5 at 6:06 PM
msn.com logoHC Wainwright & Co. Maintains Leap Therapeutics (LPTX) Buy Recommendation
msn.com - August 15 at 6:09 PM
msn.com logoBaird Maintains Leap Therapeutics (LPTX) Outperform Recommendation
msn.com - August 15 at 6:09 PM
markets.businessinsider.com logoLeap Therapeutics (LPTX) Receives a Buy from H.C. Wainwright
markets.businessinsider.com - August 15 at 7:59 AM
finanznachrichten.de logoLeap Therapeutics, Inc.: Leap Therapeutics Reports Second Quarter 2023 Financial Results
finanznachrichten.de - August 14 at 4:53 PM
finance.yahoo.com logoLeap Therapeutics Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 14 at 4:53 PM
msn.com logoRaymond James Maintains Leap Therapeutics (LPTX) Outperform Recommendation
msn.com - July 14 at 12:41 AM
finance.yahoo.com logoLeap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients
finance.yahoo.com - July 12 at 9:07 AM
msn.com logoLeap Therapeutics (LPTX) Price Target Increased by 876.00% to 24.89
msn.com - July 6 at 11:33 PM
markets.businessinsider.com logoLeap Therapeutics (LPTX) Receives a Buy from Raymond James
markets.businessinsider.com - June 23 at 12:27 PM
marketbeat.com logoLeap Therapeutics (NASDAQ:LPTX) Given New $17.00 Price Target at Raymond James
marketbeat.com - June 23 at 9:08 AM
marketwatch.com logo8-K: LEAP THERAPEUTICS, INC.
marketwatch.com - June 22 at 3:37 PM
finanznachrichten.de logoLeap Therapeutics, Inc.: Leap Therapeutics Announces Reverse Stock Split
finanznachrichten.de - June 21 at 8:14 AM
finance.yahoo.com logoLeap Therapeutics Announces Reverse Stock Split
finance.yahoo.com - June 20 at 2:45 PM
markets.businessinsider.com logoRobert W. Baird Sticks to Their Buy Rating for Leap Therapeutics (LPTX)
markets.businessinsider.com - May 29 at 3:34 PM
markets.businessinsider.com logoLeap Therapeutics (LPTX) Receives a Buy from Mizuho Securities
markets.businessinsider.com - May 26 at 2:13 AM
msn.com logoHC Wainwright & Co. Reiterates Leap Therapeutics (LPTX) Buy Recommendation
msn.com - May 16 at 9:31 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for Leap Therapeutics (LPTX)
markets.businessinsider.com - May 16 at 9:33 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Leap Therapeutics (LPTX) and Jasper Therapeutics (JSPR)
markets.businessinsider.com - May 15 at 3:04 PM
finance.yahoo.com logoLeap Therapeutics Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 15 at 10:03 AM
msn.com logoMizuho Reiterates Leap Therapeutics (LPTX) Buy Recommendation
msn.com - April 13 at 5:56 PM
finance.yahoo.com logoLeap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients
finance.yahoo.com - April 12 at 10:16 AM
finance.yahoo.com logoLeap Therapeutics (NASDAQ:LPTX) Will Have To Spend Its Cash Wisely
finance.yahoo.com - April 4 at 12:58 PM
markets.businessinsider.com logoWhat 5 Analyst Ratings Have To Say About Leap Therapeutics
markets.businessinsider.com - March 27 at 1:39 PM
markets.businessinsider.com logoMizuho Securities Remains a Buy on Leap Therapeutics (LPTX)
markets.businessinsider.com - March 24 at 2:39 PM
finanznachrichten.de logoLeap Therapeutics, Inc.: Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
finanznachrichten.de - March 24 at 9:39 AM
prnewswire.com logoLeap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
prnewswire.com - March 24 at 7:11 AM
markets.businessinsider.com logoRobert W. Baird Keeps Their Buy Rating on Leap Therapeutics (LPTX)
markets.businessinsider.com - March 20 at 2:23 PM
markets.businessinsider.com logoMizuho Securities Sticks to Its Buy Rating for Leap Therapeutics (LPTX)
markets.businessinsider.com - March 16 at 11:16 PM
finance.yahoo.com logoLeap Therapeutics Provides Update on BeiGene Option Agreement for DKN-01
finance.yahoo.com - March 16 at 6:16 PM
uk.finance.yahoo.com logoLeap Therapeutics, Inc. (LPTX)
uk.finance.yahoo.com - March 16 at 1:49 AM
marketbeat.com logoLeap Therapeutics (NASDAQ:LPTX) PT Lowered to $3.00
marketbeat.com - January 27 at 7:41 AM
benzinga.com logoSHAREHOLDER ALERT: Weiss Law Reminds LPTX, CNCE, ALBO, and CINC Shareholders About Its Ongoing Investigations
benzinga.com - January 25 at 2:36 PM
finance.yahoo.com logoLeap Therapeutics Shares Fall After Flame Biosciences Acquisition
finance.yahoo.com - January 25 at 9:36 AM
businesswire.com logoLPTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Leap Therapeutics, Inc. Is Fair to Shareholders
businesswire.com - January 24 at 6:54 PM
marketbeat.com logoHC Wainwright Weighs in on Leap Therapeutics, Inc.'s Q1 2023 Earnings (NASDAQ:LPTX)
marketbeat.com - January 20 at 8:42 AM
wsj.com logoSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Leap Therapeutics, Inc. Buyout
wsj.com - January 19 at 2:39 PM
msn.com logoHC Wainwright & Co. Maintains Buy Rating for Leap Therapeutics: Here's What You Need To Know
msn.com - January 18 at 1:47 PM
finance.yahoo.com logoLeap Therapeutics to Participate at the Piper Sandler 34th Annual Healthcare Conference
finance.yahoo.com - November 21 at 9:30 AM
finance.yahoo.com logoLeap Therapeutics Third Quarter 2022 Earnings: US$0.13 loss per share (vs US$0.14 loss in 3Q 2021)
finance.yahoo.com - November 16 at 7:51 PM
finance.yahoo.com logoLeap Therapeutics to Present Updated Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab and Preclinical Data in Colorectal Cancer Models at the SITC Annual Meeting
finance.yahoo.com - November 7 at 9:40 AM
finance.yahoo.com logoIs Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - October 26 at 8:48 AM
seekingalpha.com logoLPTX Leap Therapeutics, Inc.
seekingalpha.com - October 19 at 10:37 PM
finance.yahoo.com logoLeap Therapeutics Announces First Patient Enrolled in Part C of Phase 2 DisTinGuish Study of DKN-01 in Combination with Tislelizumab for the Treatment of Gastric or Gastroesophageal Junction Cancer
finance.yahoo.com - October 12 at 8:54 AM
Get Leap Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LPTX and its competitors with MarketBeat's FREE daily newsletter.



LPTX Media Mentions By Week

LPTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LPTX
News Sentiment

1.89

0.74

Average
Medical
News Sentiment

LPTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LPTX Articles
This Week

1

1

LPTX Articles
Average Week

Get Leap Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LPTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LPTX) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -